112 related articles for article (PubMed ID: 37566932)
21. Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer.
Zhang Z; Xu Z; Yan Y
Front Med (Lausanne); 2021; 8():793515. PubMed ID: 35096881
[No Abstract] [Full Text] [Related]
22. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis.
Zhang W; Wan S; Qu Z; Ge J; Zhang C; Li C; Jiang Y
Medicine (Baltimore); 2022 Jul; 101(29):e29710. PubMed ID: 35866781
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of m5c-related lncRNA risk model for ovarian cancer.
Wang C; Zhang C; Yang S; Xiang J; Zhou D; Xi X
J Ovarian Res; 2023 May; 16(1):96. PubMed ID: 37183262
[TBL] [Abstract][Full Text] [Related]
24. The noncoding RNAs regulating pyroptosis in colon adenocarcinoma were derived from the construction of a ceRNA network and used to develop a prognostic model.
Chen Y; Tian Z; Hou H; Gai W
BMC Med Genomics; 2022 Sep; 15(1):201. PubMed ID: 36127676
[TBL] [Abstract][Full Text] [Related]
25. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
[No Abstract] [Full Text] [Related]
26. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
Chen Y; Bi F; An Y; Yang Q
J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
[TBL] [Abstract][Full Text] [Related]
27. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer.
Ye Y; Dai Q; Qi H
Cell Death Discov; 2021 Apr; 7(1):71. PubMed ID: 33828074
[TBL] [Abstract][Full Text] [Related]
28. Identification of pyroptosis-related signature for cervical cancer predicting prognosis.
Zhou C; Li C; Zheng Y; Liu X
Aging (Albany NY); 2021 Nov; 13(22):24795-24814. PubMed ID: 34837692
[TBL] [Abstract][Full Text] [Related]
29. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma.
Song J; Sun Y; Cao H; Liu Z; Xi L; Dong C; Yang R; Shi Y
Bioengineered; 2021 Dec; 12(1):5932-5949. PubMed ID: 34488540
[TBL] [Abstract][Full Text] [Related]
30. A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation.
Gong M; Liu X; Zhao X; Wang H
BMC Cancer; 2022 Sep; 22(1):1005. PubMed ID: 36138348
[TBL] [Abstract][Full Text] [Related]
31. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
[TBL] [Abstract][Full Text] [Related]
32. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
Duan Y; Xu X
Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
[TBL] [Abstract][Full Text] [Related]
33. Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer.
Zeng T; Ye J; Wang H; Tian W
Medicine (Baltimore); 2023 Oct; 102(42):e35195. PubMed ID: 37861525
[TBL] [Abstract][Full Text] [Related]
34. A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance.
Chen L; Gao W; Lin L; Sha C; Li T; Chen Q; Wei H; Yang M; Xing J; Zhang M; Zhao S; Xu W; Li Y; Long L; Zhu X
J Ovarian Res; 2023 Sep; 16(1):186. PubMed ID: 37674251
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients.
Zheng J; Guo J; Zhu L; Zhou Y; Tong J
J Ovarian Res; 2021 Sep; 14(1):124. PubMed ID: 34560889
[TBL] [Abstract][Full Text] [Related]
36. A novel identified pyroptosis-related prognostic signature of colorectal cancer.
Zheng C; Tan Z
Math Biosci Eng; 2021 Oct; 18(6):8783-8796. PubMed ID: 34814322
[TBL] [Abstract][Full Text] [Related]
37. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
39. Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer.
Liu L; Wang Q; Zhou JY; Zhang B
J Ovarian Res; 2023 Apr; 16(1):88. PubMed ID: 37122030
[TBL] [Abstract][Full Text] [Related]
40. A novel prognostic model based on pyroptosis-related genes for multiple myeloma.
Zhang C; Wu S; Chen B
BMC Med Genomics; 2023 Feb; 16(1):32. PubMed ID: 36823654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
